PAN-346

N/A

Report date: 2024/10/22 14:50:46
NME

Base Information

Drug NamePAN-346
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAspartyl (asparaginyl) β-hydroxylase inhibitors
TargetsAspartyl (asparaginyl) β-hydroxylase
Therapy Area/IndicationsGlioblastomaAstrocytoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesPanacea Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPanacea Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsGlioblastomaAstrocytoma

Other Information

ATC CodeN/A
Related LinksN/A